BTAI PEER ANALYSIS

BioXcel Therapeutics Inc — metric-by-metric comparison with peers and the industry median

BTAIBioXcel Therapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - Specialty & Generic

Position Within Industry

0 = weak quartile, 100 = strong quartile

BTAIIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	BTAI	TRILC	HIK	DEVA	TLRY	HLN	Ind. Median
P/E	—	—	11.40●	—	—	30.79	21.35
P/B	-0.13●	0.61	1.77	0.51	0.32	1.94	1.77
EV/EBITDA	—	3.51●	8.72	6.74	—	18.90	12.18
P/S	19.75	0.23●	1.37	0.70	0.58	3.87	2.08

Financial Health
Metric	BTAI	TRILC	HIK	DEVA	TLRY	HLN	Ind. Median
Current Ratio	0.62	0.99	1.82	2.00	2.79●	0.92	2.22
Debt/Equity	-95.0%●	207.6%	61.8%	23.1%	20.4%	52.3%	46.3%
NetDebt/EBITDA	-1.44●	2.71	1.87	0.89	-0.07	3.50	1.24

Profitability
Metric	BTAI	TRILC	HIK	DEVA	TLRY	HLN	Ind. Median
Net Margin	-11,078.5%	-2.2%	12.0%	-4.4%	-158.8%	12.6%●	4.0%
ROE	—	-6.0%	16.4%●	-3.6%	-63.6%	6.3%	6.4%
ROA	-207.6%	-1.8%	7.5%●	-2.5%	-49.7%	3.2%	3.4%
EBITDA Margin	-8,509.3%	28.5%●	20.0%	12.0%	-156.2%	25.2%	18.2%

Growth + Dividend
Metric	BTAI	TRILC	HIK	DEVA	TLRY	HLN	Ind. Median
Rev. Growth	-63.3%	32.0%●	7.4%	7.7%	3.8%	-26.7%	7.5%
NI Growth	—	—	12.2%●	—	—	-14.2%	5.0%
Div. Yield	—	0.0%	5.4%●	0.0%	—	2.0%	2.0%
Payout	—	0.0%	45.2%	0.0%	—	40.0%	0.8%

Valuation
Metric	BTAI	EGRX	ASRT	Ind. Median
P/E	—	0.57	—	21.35
P/B	-0.13●	0.03	2.00	1.77
EV/EBITDA	—	1.14	—	12.18
P/S	19.75	0.03●	1.48	2.08

Financial Health
Metric	BTAI	EGRX	ASRT	Ind. Median
Current Ratio	0.62	2.16●	1.82	2.22
Debt/Equity	-95.0%●	28.4%	53.3%	46.3%
NetDebt/EBITDA	-1.44●	0.99	5.39	1.24

Profitability
Metric	BTAI	EGRX	ASRT	Ind. Median
Net Margin	-11,078.5%	6.0%●	-34.9%	4.0%
ROE	—	6.4%●	-38.8%	6.4%
ROA	-207.6%	4.0%●	-14.3%	3.4%
EBITDA Margin	-8,509.3%	22.1%●	-5.7%	18.2%

Growth + Dividend
Metric	BTAI	EGRX	ASRT	Ind. Median
Rev. Growth	-63.3%	-5.4%●	-14.2%	7.5%
NI Growth	—	-31.7%	—	5.0%
Div. Yield	—	2.8%	—	2.0%
Payout	—	1.6%	—	0.8%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on BTAI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.